US 8,435,948

Application 11/664,030 · Granted May 7, 2013

Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-fsh or anti-fshr antibody

Estimated expiration

April 16, 2028

1y 147d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Sep 27, 2005
+ 20 years
Sep 27, 2025
PTA +932d
Apr 16, 2028
No TD
—
Final
Apr 16, 2028

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
November 30, 2007
Earliest effective filing
September 27, 2005
Issue date
May 7, 2013
PTA
+932 days
Base expiry (before PTA)
September 27, 2025

September 27, 2005 + 20 years = September 27, 2025 + 932 PTA days = April 16, 2028

  • National stage entry of application PCTUS2005035019, filed Sep 27, 2005
  • PRO60/614,597 — Provisional — not used for base term
  • PRO60/620,086 — Provisional — not used for base term
  • PRO60/614,597 — Provisional — not used for base term
  • PRO60/620,086 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 11/664,030 · US 8,435,948

PatentReply compiles the prosecution history behind US 8,435,948: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8435948

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.